GMP update
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplement good manufacturing practices should not be expected to come out before the end of the year, "but certainly we should be able to get them out shortly after that," according to FDA Associate Commissioner for Regulatory Affairs Margaret O'K. Glavin. "It's really important those GMPs get out and get out expeditiously. [Center of Food Safety & Applied Nutrition Director] Bob Brackett chatted with me last week about this and how interested he is in making sure those are out there. They're important to us; they're important to you," she stressed at the Council for Responsible Nutrition's annual conference Sept. 18. O'K. Glavin encouraged members of the supplement industry to voice their desire for GMPs to regulators. "Certainly if you would continue to make known your strong desire to get those issued, that would not hurt in the least." She emphasized that regulatory processes are slow, "but where there is this confluence of the regulatory agency and the regulated industry both interested in getting them out that should make a huge difference"...
You may also be interested in...
Dietary Supplement GMPs Back To FDA; Publication Expected In June
Dietary supplement good manufacturing practices have received final clearance by the Office of Management and Budget, OMB and FDA confirmed May 9
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.